Cancer in Patients with CKD and Obesity — From Cancer Risk to Antineoplastic Dosing: The Metabolic Blind Spot in Onconephrology
Publication/Presentation Date
9-11-2026
Published In/Presented At
Sanon, J. (2026, Sept). Cancer in Patients with CKD and Obesity — From Cancer Risk to Antineoplastic Dosing: The Metabolic Blind Spot in Onconephrology. LIX Congreso Nacional e Internacional de Nefrología (LIX National and International Congress of Nephrology) International Onconephrology Symposium. León, Mexico.
Disciplines
Medicine and Health Sciences
Department(s)
Department of Emergency Medicine
Document Type
Presentation
COinS